Skip to main content
PMC home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1993 Aug;111(1):21–25. doi: 10.1017/s0950268800056636

Protective efficacy of BCG vaccine against leprosy in southern Malaŵi.

D M Baker 1, J S Nguyen-Van-Tam 1, S J Smith 1
PMCID: PMC2271193  PMID: 8348929

Abstract

This paper describes a matched case-control study to determine the efficacy of BCG vaccine in preventing the occurrence of leprosy in southern Malaŵi, a previously unstudied area. The BCG immunization rate amongst 145 individuals with leprosy was 44.8%, compared to 62.5% in 290 matched controls. The protective efficacy of BCG vaccine against leprosy in this region was estimated to be 63.6%; smallpox immunization had no effect. These findings support the view that BCG vaccine should be considered as a control measure in areas where leprosy is endemic.

Full text

PDF
25

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bechelli L. M., Lwin K., Gallego Garbajosa P., Mg-Mg-Gyi, Uemura K., Sundaresan T., Tamondong C., Matejka M., Sansarricq H., Walter J. BCG vaccination of children against leprosy: nine-year findings of the controlled WHO trial in Burma. Bull World Health Organ. 1974;51(1):93–99. [PMC free article] [PubMed] [Google Scholar]
  2. Boerrigter G., Ponnighaus J. M. Ten years' leprosy control work in Malaŵi (Central Africa)--I. Methods and outcome after treatment. Lepr Rev. 1986 Sep;57(3):199–219. doi: 10.5935/0305-7518.19860023. [DOI] [PubMed] [Google Scholar]
  3. Comstock G. W., Livesay V. T., Woolpert S. F. Evaluation of BCG vaccination among Puerto Rican children. Am J Public Health. 1974 Mar;64(3):283–291. doi: 10.2105/ajph.64.3.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Comstock G. W., Webster R. G. Tuberculosis studies in Muscogee County, Georgia. VII. A twenty-year evaluation of BCG vaccination in a school population. Am Rev Respir Dis. 1969 Dec;100(6):839–845. doi: 10.1164/arrd.1969.100.6.839. [DOI] [PubMed] [Google Scholar]
  5. Fine P. E., Ponnighaus J. M., Maine N., Clarkson J. A., Bliss L. Protective efficacy of BCG against leprosy in Northern Malawi. Lancet. 1986 Aug 30;2(8505):499–502. doi: 10.1016/s0140-6736(86)90367-3. [DOI] [PubMed] [Google Scholar]
  6. Fine P. E., Rodrigues L. C. Modern vaccines. Mycobacterial diseases. Lancet. 1990 Apr 28;335(8696):1016–1020. doi: 10.1016/0140-6736(90)91074-k. [DOI] [PubMed] [Google Scholar]
  7. Frimodt-Möller J., Acharyulu G. S., Pillai K. K. Observation concernant l'effet protecteur de la vaccination BCG parmi une population rurale du sud de l'Inde: quatrième rapport. Bull Int Union Tuberc. 1973 Jun;48(0):40–52. [PubMed] [Google Scholar]
  8. Ponnighaus J. M., Boerrigter G. Ten years' leprosy control work in Malaŵi (Central Africa)--II. Patterns of endemicity since 1973. Lepr Rev. 1986 Sep;57(3):221–236. doi: 10.5935/0305-7518.19860024. [DOI] [PubMed] [Google Scholar]
  9. Pönnighaus J. M., Fine P. E., Sterne J. A., Wilson R. J., Msosa E., Gruer P. J., Jenkins P. A., Lucas S. B., Liomba N. G., Bliss L. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet. 1992 Mar 14;339(8794):636–639. doi: 10.1016/0140-6736(92)90794-4. [DOI] [PubMed] [Google Scholar]
  10. ROSENTHAL S. R., LOEWINSOHNE, GRAHAM M. L., LIVERIGHT D., THORNE G., JOHNSON V. BCG vaccination against tuberculosis in Chicago. A twenty-year study statistically analyzed. Pediatrics. 1961 Oct;28:622–641. [PubMed] [Google Scholar]
  11. Ridley D. S., Jopling W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255–273. [PubMed] [Google Scholar]
  12. STEIN S. C., ARONSON J. D. The occurrence of pulmonary lesions in BCG-vaccinated and unvaccinated persons. Am Rev Tuberc. 1953 Nov;68(5):695–712. doi: 10.1164/art.1953.68.5.695. [DOI] [PubMed] [Google Scholar]
  13. Scott G. C., Russell D. A., Boughton C. R., Vincin D. R. Untreated leprosy: probability for shifts in Ridley-Jopling classification. Development of "flares", or disappearance of clinically apparent disease. Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):110–122. [PubMed] [Google Scholar]
  14. Smith P. G. Retrospective assessment of the effectiveness of BCG vaccination against tuberculosis using the case-control method. Tubercle. 1982 Mar;63(1):23–35. doi: 10.1016/s0041-3879(82)80006-8. [DOI] [PubMed] [Google Scholar]
  15. Smith P. G., Rodrigues L. C., Fine P. E. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol. 1984 Mar;13(1):87–93. doi: 10.1093/ije/13.1.87. [DOI] [PubMed] [Google Scholar]
  16. Stanley S. J., Howland C., Stone M. M., Sutherland I. BCG vaccination of children against leprosy in Uganda: final results. J Hyg (Lond) 1981 Oct;87(2):233–248. doi: 10.1017/s002217240006945x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES